XML 110 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
DESCRIPTION OF BUSINESS (Details)
$ in Thousands, shares in Millions
1 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2016
USD ($)
shares
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Apr. 30, 2018
item
Variable Interest Entity [Line Items]              
Number of patients | item             133
Cash and cash equivalents   $ 72,090   $ 162,636 $ 52,389 $ 48,121  
Accumulated deficit   349,024   316,257 315,921    
Negative cash flows from operating activities incurred   $ 1,441 $ 41,616 $ 68,878 $ 30,837 $ 37,521  
Viventia Bio Inc.              
Variable Interest Entity [Line Items]              
Shares of common stock issued to the selling shareholders (in shares) | shares 4.0            
Percentage of voting interests acquired 19.90%            
Period during which quarterly earn-outs are payable after date of net sales 15 years            
Period in which acquire is to use commercially reasonable efforts to achieve marketing authorizations 7 years            
Viventia Bio Inc. | Vicinium | Collaborative Arrangement, Revenue based on Specified Milestone              
Variable Interest Entity [Line Items]              
Percentage of net sales of quarterly earn-out payments during earn-out periods 2.00%            
Viventia Bio Inc. | Vicinium | Collaborative Arrangement, Revenue based on Specified Milestone | United States              
Variable Interest Entity [Line Items]              
One-time milestone payment upon first sale of product $ 12,500            
Viventia Bio Inc. | Vicinium | Collaborative Arrangement, Revenue based on Specified Milestone | Europe              
Variable Interest Entity [Line Items]              
One-time milestone payment upon first sale of product 7,000            
Viventia Bio Inc. | Vicinium | Collaborative Arrangement, Revenue based on Specified Milestone | Japan              
Variable Interest Entity [Line Items]              
One-time milestone payment upon first sale of product $ 3,000